Amanote Research
Register
Sign In
Effective Management of Venous Thromboembolism in the Community: Non-Vitamin K Antagonist Oral Anticoagulants
International Journal of General Medicine
- New Zealand
doi 10.2147/ijgm.s100299
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
May 1, 2016
Authors
Raj Patel
Publisher
Informa UK Limited
Related search
Cryptogenic Stroke Prevention Through Venous Thromboembolism Prevention: Potential and Truth in the Advent of Non-Vitamin K Antagonist Oral Anticoagulants
Journal of Cardiology Cases
Cardiovascular Medicine
Cardiology
Pharmacological Profile of Non-Vitamin K Antagonist Oral Anticoagulants
African Journal of Pharmacy and Pharmacology
Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
The Treatment of Venous Thromboembolism With New Oral Anticoagulants
Italian Journal of Medicine
Medicine
Pcv135 - Non-Vitamin K Antagonist Oral Anticoagulants Prescription Monitoring: How to Optimize Vigilance in Stroke Prevention
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
D-Dimer Levels During and After Anticoagulation Withdrawal in Patients With Venous Thromboembolism Treated With Non-Vitamin K Anticoagulants
PLoS ONE
Multidisciplinary
Patients' Serum and Urine as Easily Accessible Samples for the Measurement of Non–Vitamin K Antagonist Oral Anticoagulants
Seminars in Thrombosis and Hemostasis
Cardiovascular Medicine
Hematology
Cardiology
